Microbot Medical Inc.
MBOT | NASDAQ
$1.38
+$0.03 (+2.22%)
At close: Sep 22, 2026, 4:00 PM ET
$1.38
$0 (0.00%)
After-hours:
Sep 22, 2026, 7:41 PM ET
Market Data
Market Cap $61.52M
Enterprise Value $-4.97M
Beta 1.03
Average Volume 1.12M
Shares Outstanding (Diluted) 67.16M
Shares Change YoY 84.07%
Institutional Ownership 21.20%
Exchange NASDAQ
ISIN US59503A2042
Price Performance
Price Change 1M -10.0%
Price Change 3M -25.8%
Price Change 6M -46.6%
Price Change YTD -36.0%
Price Change 1Y -59.2%
Price Change 3Y 1.5%
Price Change 5Y -81.0%
1M CAGR (ann.) -28.6%
1Y CAGR (ann.) -56.3%
5Y CAGR (ann.) -27.8%
All-Time CAGR -40.9%
Valuation
PE Ratio -5.19
Forward PE 15.27
PEG Ratio -0.05
Forward PEG -0.81
PS Ratio 177.80
Forward PS 9.60
PB Ratio 0.89
P/FCF Ratio -3.43
P/Adj. FCF Ratio -3.21
P/OCF Ratio -5.19
EV/Sales -14.37
EV/EBIT 0.30
EV/EBITDA 0.31
EV/FCF 0.28
Earnings Yield -19.3%
FCF Yield -29.1%
Adj. FCF Yield -31.1%
Financial Health
Net Cash $66.49M
Total Debt $876K
Cash & Short-Term Investments $67.37M
Total Assets $73.37M
Current Ratio 18.56
Quick Ratio 17.82
Debt / Equity Ratio 0.01
Debt / EBITDA -0.05
Debt / FCF -0.05
OCF / Debt -20.14
Interest Coverage 0.00
Altman Z-Score 6.54
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin -185.3%
Operating Profit Margin -5348.8%
EBITDA Margin -4705.2%
Net Profit Margin -4722.3%
FCF Margin -5181.8%
Adj. FCF Margin -5534.1%
SBC / Revenue 352.3%
SBC Impact (per share) -6.8%
Returns
Return on Assets -22.3%
Return on Equity -21.9%
Return on Invested Capital -26.5%
Return on Capital Employed -26.6%
Return on Tangible Assets -22.3%
Historical Growth (CAGR)
Revenue CAGR 3Y 150.0%
Revenue CAGR 5Y 100.0%
Revenue CAGR 10Y 11.3%
EPS CAGR 3Y 48.0%
EPS CAGR 5Y 39.6%
EPS CAGR 10Y 20.1%
FCF CAGR 3Y -42.1%
FCF CAGR 5Y -11.0%
FCF CAGR 10Y -42.3%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 4
EPS Growth Next 3Y 21.8%
Revenue Growth Next 3Y 418.4%
Earnings Date Nov 10, 2026
EPS Estimate (next Q) -$0.08
EPS Growth Est (next Q) 14.3%
Revenue Est (next Q) $261.33K
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $4
Price Target Upside 196.3%
Cash Flow
Operating Cash Flow $-17.64M
Free Cash Flow $-17.93M
Adj. Free Cash Flow $-19.15M
FCF Per Share -$0.27
OCF Per Share -$0.26
OCF/S Ratio -5098.6%
Income Statement
Revenue $346K
Gross Profit $-641K
Operating Income $-18.51M
EBITDA $-16.28M
Net Income $-16.34M
EPS (Diluted) -$0.26
Revenue / Employee $8.05K
Profit / Employee $-379.98K
Employees 43
Add to Watchlist
Select watchlists to add or remove MBOT